BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17347010)

  • 1. Assessment of hydration by means of bioelectrical impedance and arm muscle area during growth hormone (GH) replacement therapy: A prospective study of 130 GH-deficient patients.
    Badre-Esfahani S; Nellemann B; Danielsen D; Fisker S; Christiansen JS; Jørgensen JO
    Growth Horm IGF Res; 2007 Jun; 17(3):227-33. PubMed ID: 17347010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
    Götherström G; Bengtsson BA; Sunnerhagen KS; Johannsson G; Svensson J
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone deficiency (GHD) in adult thalassaemic patients.
    Scacchi M; Danesi L; Cattaneo A; Valassi E; Pecori Giraldi F; Argento C; D'Angelo E; Mirra N; Carnelli V; Zanaboni L; Cappellini MD; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):790-5. PubMed ID: 17608814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis.
    de Boer H; Blok GJ; Voerman B; de Vries P; Popp-Snijders C; van der Veen E
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2069-76. PubMed ID: 7608257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
    Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K
    Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study.
    Valk NK; vd Lely AJ; de Herder WW; Lindemans J; Lamberts SW
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1070-6. PubMed ID: 7525625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
    Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
    Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults.
    Ehrnborg C; Ellegård L; Bosaeus I; Bengtsson BA; Rosén T
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):449-57. PubMed ID: 15807876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy.
    Colao A; Di Somma C; Savanelli MC; De Leo M; Lombardi G
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S41-8. PubMed ID: 16690338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency.
    Sartorio A; Agosti F; De Col A; Mazzilli G; Marazzi N; Busti C; Galli R; Lafortuna CL
    Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in body composition in adult patients with hypopituitarism after substitutive treatment with growth hormone].
    Gómez Sáez JM; Gómez Arnaiz N; Soler Ramón J
    Med Clin (Barc); 1999 Sep; 113(7):246-9. PubMed ID: 10544378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
    Karavitaki N; Warner JT; Marland A; Shine B; Ryan F; Arnold J; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 May; 64(5):556-60. PubMed ID: 16649976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis.
    De Boer H; Blok GJ; Voerman HJ; De Vries PM; van der Veen EA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):833-7. PubMed ID: 1517374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.